结合常规临床指标的临床预测模型在识别由内源性胰岛素分泌维持定义的青年起病2型糖尿病中具有高准确性:SEARCH for Diabetes in Youth研究
研究纳入2966例青年糖尿病患者,构建预测模型以识别糖尿病病程超过3年(中位74个月)后空腹C肽≥250 pmol/L(≥0.75 ng/mL)者。使用常规临床指标联合或不联合胰岛自身抗体及1型糖尿病遗传风险评分的模型AUCROC为0.95-0.98,内部验证乐观度低、校准良好。
要点
- 使用常规临床指标联合或不联合自身抗体和T1DGRS的模型识别C肽≥0.75 ng/mL的AUCROC为0.95-0.98。
- C肽≥0.75 ng/mL者占17%,自身抗体阳性者中占2.3%,自身抗体阴性者中占53%。
- 模型在肥胖、不同种族/ ethnicity、自身抗体状态及临床诊断糖尿病类型亚组中AUCROC为0.81-0.97。
核心结论
- 结合糖尿病诊断时常规临床指标、联合或不联合胰岛自身抗体或T1DGRS的预测模型,可准确识别内源性胰岛素分泌维持在T2D相关范围的青年糖尿病患者。
研究设计与样本
- 前瞻性SEARCH for Diabetes in Youth研究,纳入2966例诊断年龄≤19岁的青年糖尿病患者,构建预测模型。
- 模型纳入基线访视时(平均糖尿病病程11个月)的年龄、BMI、性别、腰围、HDL胆固醇,联合或不联合胰岛自身抗体(GADA、IA-2A)及1型糖尿病遗传风险评分(T1DGRS)。
主要发现
- 研究以糖尿病病程>3年(中位74个月)后空腹C肽≥250 pmol/L(≥0.75 ng/mL)定义结局,该人群占17%,在自身抗体阳性者中占2.3%,在自身抗体阴性者中占53%。
- 使用常规临床指标联合或不联合自身抗体和T1DGRS的模型识别C肽≥0.75 ng/mL的AUCROC为0.95-0.98。
- 内部验证中乐观度极低,校准优秀(斜率0.995-0.999)。
- 模型在肥胖较年长青年中预测保留C肽的AUCROC为0.88-0.96,在自我报告的种族和族裔亚组中AUCROC为0.88-0.97,在自身抗体状态亚组中AUCROC为0.87-0.96,在临床诊断糖尿病类型亚组中AUCROC为0.81-0.92。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: With high prevalence of obesity and overlapping features between diabetes subtypes, accurately classifying youth-onset diabetes can be challenging. We aimed to develop prediction models that, using characteristics available at diabetes diagnosis, can identify youth who will retain endogenous insulin secretion at levels consistent with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We studied 2,966 youth with diabetes in the prospective SEARCH for Diabetes in Youth study (diagnosis age ≤19 years) to develop prediction models to identify participants with fasting C-peptide ≥250 pmol/L (≥0.75 ng/mL) after >3 years' (median 74 months) diabetes duration. Models included clinical measures at the baseline visit, at a mean diabetes duration of 11 months (age, BMI, sex, waist circumference, HDL cholesterol), with and without islet autoantibodies (GADA, IA-2A) and a type 1 diabetes genetic risk score (T1DGRS). RESULTS: Models using routine clinical measures with or without autoantibodies and T1DGRS were highly accurate in identifying participants with C-peptide ≥0.75 ng/mL (17% of participants; 2.3% and 53% of those with and without positive autoantibodies) (area under the receiver operating characteristic curve [AUCROC] 0.95-0.98). In internal validation, optimism was very low, with excellent calibration (slope 0.995-0.999). Models retained high performance for predicting retained C-peptide in older youth with obesity (AUCROC 0.88-0.96) and in subgroups defined by self-reported race and ethnicity (AUCROC 0.88-0.97), autoantibody status (AUCROC 0.87-0.96), and clinically diagnosed diabetes types (AUCROC 0.81-0.92). CONCLUSIONS: Prediction models combining routine clinical measures at diabetes diagnosis, with or without islet autoantibodies or T1DGRS, can accurately identify youth with diabetes who maintain endogenous insulin secretion in the range associated with T2D.
引用
- Jones AG, Shields BM, Oram RA, et al. Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2024. PMID: 38252849. doi:10.2337/dc23-1815
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。